Hippo Dx

More accurate, faster and efficient allergy testing with automated skin prick tests

Hippo Dx, a MedTech company, was born in 2020 out of the need for automation, standardisation, and digitisation in skin prick allergy testing. Today, 30% of the world's population suffers from allergies, but 45% face initial misdiagnosis. The limitation of manual testing prompted Senne Gorris, an ENT surgeon, to envision an innovative solution. Joined by a team of mechatronics and software engineers, they developed S.P.A.T. (Skin Prick Automated Test), a state-of-the-art medical device for allergy testing.

Developed by physicians and designed for patients, S.P.A.T. offers faster, more accurate, and more consistent allergy testing and readout.